514 results on '"Panidis, Dimitrios"'
Search Results
2. Oral contraceptives increase platelet microparticle levels in normal-weight women with polycystic ovary syndrome
3. Right hemicolectomy vs. appendectomy in patients with appendiceal NENs 1-2cm in size
4. Late Pregnancy Complications in Polycystic Ovary Syndrome
5. Uterine Volume and Endometrial Thickness in the Early Follicular Phase in Patients with Polycystic Ovary Syndrome
6. Hyperandrogenism in PCOS
7. Oral contraceptives increase platelet microparticle levels in normal-weight women with polycystic ovary syndrome
8. Lipid accumulation product is associated with metabolic syndrome in women with polycystic ovary syndrome
9. Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome
10. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome
11. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome
12. Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
13. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome
14. Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
15. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome
16. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome
17. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome
18. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis
19. The bencfit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers
20. Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
21. Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome
22. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
23. Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome
24. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration
25. Plasma Von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome
26. The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology
27. Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome
28. Plasma visfatin levels in normal weight women with polycystic ovary syndrome
29. The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome
30. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels
31. Hormone therapy and asymmetrical dimethylarginine in postmenopausal women
32. Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome
33. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome
34. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
35. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
36. Lipid and lipoprotein profile in women with polycystic ovary syndrome (1)
37. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries
38. Novel Insights into the Pathophysiology & Treatment of PCOS
39. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome
40. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia
41. Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
42. Increased Frequency of the Anti-Müllerian-Inhibiting Hormone Receptor 2 (AMHR2) 482 A>G Polymorphism in Women With Polycystic Ovary Syndrome: Relationship to Luteinizing Hormone Levels
43. Metabolic syndrome in patients with the polycystic ovary syndrome
44. Prevalence of metabolic syndrome in women with polycystic ovary syndrome
45. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome
46. Strong and Positive Association of Endothelin-1 with Advanced Glycated End Products in PCOS
47. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Blood Levels of Bisphenol A in PCOS Women.
48. Serum Concentrations of Carboxylated Osteocalcin Are Increased and Associated with the Components of the Polycystic Ovarian Syndrome.
49. Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations
50. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.